What You 100% Absolutely Need to Know Before Even Thinking About Investing in the SpaceX IPOApril 23, 2026
Theravance Biopharma, Inc. 2025 Q3 – Results – Earnings Call Presentation (NASDAQ:TBPH) 2025-11-11 Finances November 12, 2025 Q3: 2025-11-10 Earnings AbstractEPS of $0.04 beats by $0.09 | Income of $19.99M (18.51% Y/Y) beats by $96.50KThis text was written…
Credit Suisse says large cap biopharma offers defense in macro storm (NYSE:PFE) Markets November 20, 2022 Oleg Elkov Citing historic efficiency and fundamentals, Credit score Suisse recognized U.S. large-cap biopharma as a beautiful defensive pocket amid…
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022 Markets September 13, 2022 HILLSIDE, NJ / ACCESSWIRE / September 13, 2022 / Built-in BioPharma, Inc. (OTCQX:INBP) (the “Firm” or “INBP”) reviews its monetary…
Drug pricing legislation will affect biopharma revenue, but impact is manageable – RBC Finances July 23, 2022 Dave Kotinsky/Getty Pictures Leisure Proposed drug pricing laws from Senate Democrats, if handed, would have an effect on income for…
CTI BioPharma Corp.: Pacritinib Approval, Downgrade To A Sell Rating (NASDAQ:CTIC) Finances April 11, 2022 This text was written byComply withWe concentrate on small and mid-cap healthcare and expertise firms. We publish quick and lengthy…
